Page last updated: 2024-11-03

propafenone and Amentia

propafenone has been researched along with Amentia in 1 studies

Propafenone: An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity.
propafenone : An aromatic ketone that is 3-(propylamino)propane-1,2-diol in which the hydrogen of the primary hydroxy group is replaced by a 2-(3-phenylpropanoyl)phenyl group. It is a class 1C antiarrhythmic drug with local anesthetic effects, and is used as the hydrochloride salt in the management of supraventricular and ventricular arrhythmias.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
La Rocca, R1
Ferrari-Toninelli, G1
Patanè, S1

Other Studies

1 other study available for propafenone and Amentia

ArticleYear
Widened QRS interval and left ventricular systolic depression after propafenone and promazine exposure.
    International journal of cardiology, 2014, Nov-15, Volume: 177, Issue:1

    Topics: Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Dementia; Dopamine Antagonists; Dose

2014